FDA OKs Botox for Upper Limb Spasticity in Children FDA OKs Botox for Upper Limb Spasticity in Children

Botox is the first neurotoxin to be approved in the US to treat upper limb spasticity for pediatric patients aged 2 years and older.FDA Approvals

Source: Medscape Neurology and Neurosurgery Headlines - June 24, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news